Completed PHASE4 INTERVENTIONAL 4-arm NCT01246999

Effect of Age and Prior Immunity to Response to Seasonal Influenza Vaccines in Children

Evaluation of the Effect of Age and Prior Immunity on the Response to Live or Inactivated Seasonal (A/California/7/2009-like, A/Perth/16/2009-like, and B/Brisbane/60/2008-like (B/Victoria Lineage) Influenza Vaccines in Children

Sponsor: Dartmouth-Hitchcock Medical Center

Conditions Influenza

Interventions LAIV followed by TIV Live attenuated Influenza vaccine TIV followed by LAIV Trivalent Influenza Vaccine

Updated 6 times since 2017 Last updated: Nov 10, 2016 Started: Oct 31, 2010 Primary completion: Jan 31, 2013 Completion: Jun 30, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Influenza, this trial is completed. The trial is conducted by Dartmouth-Hitchcock Medical Center and has accumulated 6 data snapshots since 2010. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Feb 2017 — Jun 2018 [monthly]

Completed PHASE4

▶ Show 1 earlier version

Jan 2017 — Feb 2017 [monthly]

Completed PHASE4

First recorded

Oct 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dartmouth-Hitchcock Medical Center
National Institutes of Health (NIH)
University of Rochester

Data source: University of Rochester

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Lebanon, United States
• Rochester, United States